are glp-1 drugs safe Researchers find medications to continue before surgery in patients with diabetes and obesity A schematic overview of GLP-1

Remember, we should never go to a doctors appointment seeking prescriptions

Nevertheless, it is crucial to consider the potential adverse effects of weight fluctuation after discontinuing these medications, particularly the increased risk of cardiovascular and all-cause mortality in patients with obesity or overweight

Subsequently, in August 2025, semaglutide, a representative drug of GLP-1RAs, also obtained FDA approval, targeting the same indications as Resmetirom (8)

This is the reason a higher A1c lowering effect is observed with GLP1 agonists, due to the FPG lowering effect

Tang and colleagues divided the participants into three comparison cohorts: GLP-1 receptor agonist (n = 10,212) vs